VIMOVO
VIMOVO
Approved
DIN Number
02361701
Drug Class
Human
Market Date
Feb 4, 2011
Company
HC
xediton pharmaceuticals inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02361701
AIG Number0252870001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AE52 NAPROXEN AND ESOMEPRAZOLE
Product Specifications
Dosage FormTablet (Immediate And Delayed-Release)
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification
ACTIVE INGREDIENTS (2)
ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)Active
Strength: 20 MG
Monograph: ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)
NAPROXENActive
Strength: 375 MG
Monograph: NAPROXEN